The pharmaceutical world is buzzing by the prospect of GLP-1 transdermal systems . Currently, GLP-1 drugs are primarily administered via needles, which can be a deterrent for some patients . These topical https://www.bigdaishowa.eu/sites/detail/?p=Tirzepatide-News-Update--Microdosing-Research-and-2026-Access-Options-AdC9sR7dUjSUD